PFIZER COMMITS $15 MILLION FOR MALARIA IN AFRICA
Pfizer has announced a $15 million commitment that will help close critical treatment gaps in malaria for patients in Senegal, Ghana and Kenya. Through the Clinton Global Initiative, Pfizer will partner with governments, leading local and international organizations like the World Health Organization and the President's Malaria Initiative, and non-governmental organizations to help develop and strengthen programs for the effective treatment and management of malaria.
Through the five-year malaria initiative, the company will provide grants and Pfizer Global Health Fellow expertise to support programs that improve patients' understanding of appropriate treatment and patient care, especially in the non-traditional informal health sector where sub-optimal diagnosis and treatment is offered.
Pfizer also has a research program focused on malaria. Scientists are developing a potential treatment based on its widely used antibiotic Zithromax. Dosed in combination with chloroquine, Zithromax has demonstrated promising results against malaria in a pilot study.
Upcoming Events
-
21Oct